The Fresenius Kabi 0.9% Sodium Chloride IV Solution is a sterile, isotonic intravenous solution used for fluid replacement, electrolyte replenishment, and as a vehicle for the administration of compatible intravenous medications. Providing sodium chloride at physiological concentrations (9 mg/mL NaCl), this solution is suitable for a wide range of clinical applications in hospitals, clinics, and emergency care settings across Australia.

Presented in flexible plastic infusion bags (Freeflex or Ecoflac formats) in sterile, single-use packaging, the solution is pyrogen-free and suitable for peripheral or central IV administration. Compatible with many IV medications (verify drug-specific compatibility before use). Latex-free and DEHP-free packaging options are available. Monitor fluid balance, electrolytes, and acid-base status during prolonged therapy. Use with caution in patients with hypertension, oedema, or pre-existing heart disease.

Specifications

• Concentration: 0.9% Sodium Chloride (9 mg/mL NaCl)
• Osmolarity: Approximately 308 mOsm/L (isotonic)
• pH range: 4.5–7.0
• Volume options: 100 mL, 250 mL, 500 mL, and 1000 mL
• Presentation: Flexible plastic infusion bag (Freeflex or Ecoflac)
• Packaging: Sterile, single-use

Indications

• Treatment of isotonic extracellular fluid loss
• Vehicle for compatible IV drug delivery
• Restoring or maintaining electrolyte balance
• Initial fluid therapy for dehydration or shock

Contraindications

• Severe renal impairment (risk of sodium retention and fluid overload)
• Congestive heart failure or conditions with sodium retention
• Hypernatremia or hyperchloremia
• Conditions requiring fluid restriction

Ideal For

• Hospital wards, emergency departments, and clinical settings
• IV fluid replacement and electrolyte management
• IV medication delivery in healthcare facilities across Australia